PARNATE- tranylcypromine sulfate tablet, film coated 
Covis Pharmaceuticals Inc

----------

Medication Guide

Antidepressant Medicines, Depression and Other Serious Mental Illnesses, and Suicidal Thoughts or Actions

PARNATE® (PAR-nate) (tranylcypromine sulfate) Tablets

Read the Medication Guide that comes with you or your family member’s antidepressant medicine. This Medication Guide is only about the risk of suicidal thoughts and actions with antidepressant medicines. Talk to your, or your family member’s, healthcare provider about:

What is the most important information I should know about antidepressant medicines, depression and other serious mental illnesses, and suicidal thoughts or actions?

1. Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults within the first few months of treatment.

2. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a particularly high risk of having suicidal thoughts or actions. These include people who have (or have a family history of) bipolar illness (also called manic-depressive illness) or suicidal thoughts or actions.

3. How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?

Call a healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you:

What else do I need to know about antidepressant medicines?

This Medication Guide has been approved by the U.S. Food and Drug Administration for all antidepressants.

June 2012                                                                                         100026

Covis

Distributed by Covis Pharmaceuticals, Inc.
Cary, NC 27511

Manufactured by GlaxoSmithKline
Mississauga, ON, Canada L5N 6L4

©2012, Covis Pharmaceuticals, Inc. All rights reserved.

June 2012                                                                                         100026

Revised: 01/2013
 
Covis Pharmaceuticals Inc